Ibrance

Product NDC
63539-486
11-digit product format
635390486
Labeler code
63539
Product ID
63539-486_bdba8a62-3a62-4485-a053-e496ad7dda13
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
palbociclib
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
U.S. Pharmaceuticals
Application
NDA212436
Marketing category
NDA
Marketing start
2020-03-30
Substance
PALBOCICLIB
Active strength
100 mg/1
Pharmacologic classes
Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ibrance
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PALBOCICLIB100 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiG9ZF61LE7G
Rxcui2284102, 2284104, 2284105, 2284106, 2284107, 2284108

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c1f85e95-ece0-4b26-a786-e9ff64eb69dcProduct name120200415
5a4db755-de93-485c-89bf-cac499b46d8cProduct name220160328

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63539-486-03Ibrance3 in 1 CARTONTABLET, FILM COATED39
63539-486-07Ibrance7 in 1 DOSE PACKTABLET, FILM COATED79

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63539-486IBRANCE (PALBOCICLIB) TABLET, FILM COATED [U.S. PHARMACEUTICALS]7Current NDC, Legacy NDC, 2 package rows20250426_89a142d5-7e61-48bf-9e77-e2cd124c4792.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2284104Ibrance 100 MG Oral TabletPSN89a142d5-7e61-48bf-9e77-e2cd124c479210
2284106Ibrance 125 MG Oral TabletPSN89a142d5-7e61-48bf-9e77-e2cd124c479210
2284108Ibrance 75 MG Oral TabletPSN89a142d5-7e61-48bf-9e77-e2cd124c479210
2284102palbociclib 100 MG Oral TabletPSN89a142d5-7e61-48bf-9e77-e2cd124c479210
2284105palbociclib 125 MG Oral TabletPSN89a142d5-7e61-48bf-9e77-e2cd124c479210
2284107palbociclib 75 MG Oral TabletPSN89a142d5-7e61-48bf-9e77-e2cd124c479210
2284104palbociclib 100 MG Oral Tablet [Ibrance]SBD89a142d5-7e61-48bf-9e77-e2cd124c479210
2284106palbociclib 125 MG Oral Tablet [Ibrance]SBD89a142d5-7e61-48bf-9e77-e2cd124c479210
2284108palbociclib 75 MG Oral Tablet [Ibrance]SBD89a142d5-7e61-48bf-9e77-e2cd124c479210
2284102palbociclib 100 MG Oral TabletSCD89a142d5-7e61-48bf-9e77-e2cd124c479210
2284105palbociclib 125 MG Oral TabletSCD89a142d5-7e61-48bf-9e77-e2cd124c479210
2284107palbociclib 75 MG Oral TabletSCD89a142d5-7e61-48bf-9e77-e2cd124c479210
2284104Ibrance 100 MG Oral TabletSY89a142d5-7e61-48bf-9e77-e2cd124c479210
2284106Ibrance 125 MG Oral TabletSY89a142d5-7e61-48bf-9e77-e2cd124c479210
2284108Ibrance 75 MG Oral TabletSY89a142d5-7e61-48bf-9e77-e2cd124c479210

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63539-486-03635390486033 DOSE PACK in 1 CARTON (63539-486-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-486-07) 3 dose pack2020-03-300000-00-00NoNoCurrent
63539-486-07635390486077 in 1 DOSE PACKHistorical